Spots Global Cancer Trial Database for untreated adult acute myeloid leukemia

Every month we try and update this database with for untreated adult acute myeloid leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia	NCT00002549	Leukemia	filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mesna mitoxantrone hy... allogeneic bone... autologous bone... peripheral bloo... radiation thera...	15 Years - 60 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia	NCT00003602	Leukemia Myelodysplastic...	cytarabine etoposide idarubicin mitoxantrone hy...	55 Years -	National Cancer Institute (NCI)
Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome	NCT00445744	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Childhood Acute... Childhood Myelo... de Novo Myelody... Essential Throm... Myelodysplastic... Polycythemia Ve... Previously Trea... Primary Myelofi... Recurrent Adult... Recurrent Child... Secondary Acute... Secondary Myelo... Secondary Myelo... Untreated Adult... Untreated Child...	cyclophosphamid... busulfan tacrolimus methotrexate cytogenetic ana... flow cytometry pharmacological... pharmacogenomic... peripheral bloo... allogeneic hema...	- 65 Years	Fred Hutchinson Cancer Center
Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia	NCT00004128	Leukemia	aldesleukin filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide autologous bone... peripheral bloo... radiation thera...	15 Years - 60 Years	National Cancer Institute (NCI)
6,8-Bis(Benzylthio)Octanoic Acid, Cytarabine, and Daunorubicin Hydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT02472626	Untreated Adult...	6,8-Bis(benzylt... Cytarabine Daunorubicin Hy...	60 Years -	Wake Forest University Health Sciences
Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia	NCT00039117	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Secondary Acute... Untreated Adult...	oblimersen sodi... cytarabine daunorubicin hy... laboratory biom... pharmacological...	60 Years -	National Cancer Institute (NCI)
Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS	NCT02921061	Mixed Phenotype... Previously Trea... Recurrent Adult... Recurrent High ... Refractory Acut... Refractory High... Untreated Adult...	Cladribine Cytarabine Decitabine Filgrastim Laboratory Biom... Mitoxantrone Hy...	18 Years -	Fred Hutchinson Cancer Center
Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531	NCT01407757	Leukemia	DNA analysis gene expression... laboratory biom... pharmacogenomic...	- 29 Years	Children's Oncology Group
Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia	NCT03009240	Acute Myeloid L... Recurrent Acute... Refractory Acut... Secondary Acute... Therapy-Related... Untreated Adult...	Decitabine Laboratory Biom... Pevonedistat Pharmacological...	18 Years -	City of Hope Medical Center
Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia	NCT00818649	Leukemia Myelodysplastic...	bortezomib vorinostat	18 Years -	Masonic Cancer Center, University of Minnesota
Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome	NCT00475150	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... de Novo Myelody... Previously Trea... Recurrent Adult... Secondary Acute... Secondary Myelo... Untreated Adult...	cediranib malea... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia	NCT02381548	Acute Myeloid L... Blast Phase Chr... Myelodysplastic... Previously Trea... Recurrent Adult... Recurrent Chron... Refractory Acut... Refractory Chro... Secondary Acute... Therapy-Related... Untreated Adult...	Adavosertib Belinostat Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia	NCT00003230	Leukemia	paclitaxel	18 Years - 75 Years	Swiss Group for Clinical Cancer Research
Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia	NCT00093483	Leukemia	filgrastim arsenic trioxid... cytarabine idarubicin	18 Years - 59 Years	Roswell Park Cancer Institute
S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia	NCT00066794	Leukemia	filgrastim sargramostim cyclosporine cytarabine daunorubicin hy...	56 Years -	SWOG Cancer Research Network
Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia	NCT00602771	Acute Myeloid L... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult...	tipifarnib etoposide	70 Years -	National Cancer Institute (NCI)
VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies	NCT00070538	Leukemia Myelodysplastic...	cytarabine laromustine	18 Years -	National Cancer Institute (NCI)
S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT00004217	Leukemia	filgrastim sargramostim cytarabine daunorubicin hy... valspodar	56 Years -	SWOG Cancer Research Network
Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT00003268	Drug/Agent Toxi... Leukemia	amifostine trih... cytarabine idarubicin	18 Years -	National Cancer Institute (NCI)
Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia	NCT00528450	Leukemia	arsenic trioxid... idarubicin tretinoin	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome	NCT00002800	Leukemia Myelodysplastic... Neutropenia	filgrastim lintuzumab cytarabine etoposide idarubicin	18 Years -	Memorial Sloan Kettering Cancer Center
Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma	NCT00079378	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Recurrent Adult... Recurrent Small... Refractory Chro... Untreated Adult...	decitabine valproic acid pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)
S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia	NCT01338974	Leukemia	gene expression... proteomic profi... flow cytometry laboratory biom...	56 Years -	SWOG Cancer Research Network
Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia	NCT00528398	Leukemia	cytarabine idarubicin	16 Years - 60 Years	City of Hope Medical Center
Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT00274807	Leukemia	filgrastim cytarabine etoposide mitoxantrone hy...	16 Years -	The Cleveland Clinic
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer	NCT00027820	Adult Acute Mye... Childhood Acute... Childhood Acute... Childhood Myelo... Childhood Renal... Chronic Myelomo... Clear Cell Rena... de Novo Myelody... Metastatic Rena... Previously Trea... Progression of ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Refractory Anem... Refractory Anem... Refractory Chil... Refractory Chro... Renal Medullary... Type 1 Papillar... Type 2 Papillar... Untreated Adult... Untreated Adult... Untreated Child...	Fludarabine Pho... Total-Body Irra... Peripheral Bloo... Nonmyeloablativ... Cyclosporine Mycophenolate M...	-	Fred Hutchinson Cancer Center
Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS	NCT01141725	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... de Novo Myelody... Myelodysplastic... Untreated Adult...	bendamustine hy... idarubicin	50 Years -	Fred Hutchinson Cancer Center
Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT00124644	Leukemia	cytarabine daunorubicin hy... etoposide tipifarnib chemotherapy enzyme inhibito... high-dose chemo...	18 Years - 59 Years	National Cancer Institute (NCI)
Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia	NCT00004215	Anemia Leukemia Neutropenia Thrombocytopeni...	filgrastim leridistim cytarabine daunorubicin hy...	55 Years -	Memorial Sloan Kettering Cancer Center
Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia	NCT00006122	Leukemia	cytarabine etoposide gemtuzumab ozog... idarubicin mitoxantrone hy...	61 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT00112853	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult...	tipifarnib etoposide	70 Years -	National Cancer Institute (NCI)
Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT01349972	Acute Myeloid L... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult...	alvocidib daunorubicin hy... mitoxantrone hy... cytarabine	18 Years - 70 Years	National Cancer Institute (NCI)
Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy	NCT01235572	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Previously Trea... Recurrent Adult...	standard follow... medical chart r... quality-of-life...	18 Years - 75 Years	Fred Hutchinson Cancer Center
Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients	NCT01633099	Untreated Adult... Effect of Drugs Drug Safety	Decitabine	60 Years -	ChineseAMS
S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia	NCT01434329	Leukemia	DNA methylation... gene expression... microarray anal... laboratory biom... medical chart r...	18 Years -	SWOG Cancer Research Network
Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia	NCT01839240	Adult Acute Meg... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... Secondary Acute... Untreated Adult...	azacitidine cytarabine mitoxantrone hy... laboratory biom...	18 Years -	University of Chicago
S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia	NCT00899743	Leukemia	polyacrylamide ... western blottin... immunologic tec... laboratory biom...	56 Years -	SWOG Cancer Research Network
Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia	NCT00278330	Blastic Phase C... Recurrent Adult... Recurrent Adult... Refractory Anem... Relapsing Chron... Untreated Adult... Untreated Adult...	alvocidib vorinostat	18 Years -	National Cancer Institute (NCI)
Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome	NCT00445744	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Childhood Acute... Childhood Myelo... de Novo Myelody... Essential Throm... Myelodysplastic... Polycythemia Ve... Previously Trea... Primary Myelofi... Recurrent Adult... Recurrent Child... Secondary Acute... Secondary Myelo... Secondary Myelo... Untreated Adult... Untreated Child...	cyclophosphamid... busulfan tacrolimus methotrexate cytogenetic ana... flow cytometry pharmacological... pharmacogenomic... peripheral bloo... allogeneic hema...	- 65 Years	Fred Hutchinson Cancer Center
Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia	NCT00027872	Acute Myeloid L... Adult Acute Bas... Adult Acute Eos... Adult Acute Ery... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Cellular Diagno... Untreated Adult...	tipifarnib laboratory biom...	65 Years -	National Cancer Institute (NCI)
Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia	NCT00742625	Acute Myeloid L... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Untreated Adult...	daunorubicin hy... cytarabine bortezomib	60 Years - 75 Years	National Cancer Institute (NCI)
Empirical Versus Preemptive Antifungal Therapy	NCT01288378	Fungal Infectio... Leukemia Myelodysplastic...	caspofungin ace...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML	NCT01690065	Chronic Myeloid... Untreated Adult...	Nilotinib+AD in...	18 Years - 65 Years	Ulsan University Hospital
VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia	NCT00354276	Leukemia	cytarabine laromustine	60 Years -	National Cancer Institute (NCI)
Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia	NCT00742625	Acute Myeloid L... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Untreated Adult...	daunorubicin hy... cytarabine bortezomib	60 Years - 75 Years	National Cancer Institute (NCI)
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes	NCT00454480	Leukemia Myelodysplastic...	alemtuzumab arsenic trioxid... azacitidine busulfan clofarabine cytarabine daunorubicin hy... fludarabine pho... gemtuzumab ozog... melphalan tipifarnib DNA methylation... cytogenetic ana... gene expression... mutation analys... diagnostic labo... immunologic tec... allogeneic hema... nonmyeloablativ...	-	National Cancer Institute (NCI)
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia	NCT00002549	Leukemia	filgrastim busulfan cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mesna mitoxantrone hy... allogeneic bone... autologous bone... peripheral bloo... radiation thera...	15 Years - 60 Years	National Cancer Institute (NCI)
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome	NCT00801489	Acute Myeloid L... Acute Myeloid L... Acute Myeloid L... de Novo Myelody... High Risk Myelo... Inv(16) Myelodysplastic... t(16;16) t(8;21) Untreated Adult...	Cytarabine Decitabine Filgrastim-sndz Fludarabine Pho... Gemtuzumab Ozog... Idarubicin Laboratory Biom...	18 Years -	M.D. Anderson Cancer Center
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT00651261	Leukemia	cytarabine daunorubicin midostaurin placebo dexamethasone a...	18 Years - 59 Years	Alliance for Clinical Trials in Oncology
VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies	NCT00070538	Leukemia Myelodysplastic...	cytarabine laromustine	18 Years -	National Cancer Institute (NCI)
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia	NCT00897936	Leukemia	DNA methylation... comparative gen... fluorescence in... microarray anal... polymerase chai... diagnostic labo... immunologic tec...	18 Years - 120 Years	Eastern Cooperative Oncology Group
S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia	NCT00899743	Leukemia	polyacrylamide ... western blottin... immunologic tec... laboratory biom...	56 Years -	SWOG Cancer Research Network
S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia	NCT00005866	Leukemia Myelodysplastic...	busulfan cyclophosphamid... cyclosporine methotrexate allogeneic bone... radiation thera...	16 Years - 55 Years	SWOG Cancer Research Network
Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML	NCT01849276	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Blastic Phase C... Recurrent Adult... Untreated Adult...	metformin hydro... cytarabine laboratory biom...	18 Years -	Northwestern University
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia	NCT01385150	Leukemia	mutation analys... protein analysi... laboratory biom... liquid chromato... mass spectromet...	17 Years - 60 Years	Eastern Cooperative Oncology Group
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia	NCT00052299	Leukemia	cytarabine etoposide gemtuzumab ozog... idarubicin mitoxantrone hy...	61 Years - 75 Years	European Organisation for Research and Treatment of Cancer - EORTC
Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia	NCT00027872	Acute Myeloid L... Adult Acute Bas... Adult Acute Eos... Adult Acute Ery... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Cellular Diagno... Untreated Adult...	tipifarnib laboratory biom...	65 Years -	National Cancer Institute (NCI)
Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies	NCT01564277	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Blastic Phase C... Contiguous Stag... de Novo Myelody... Noncontiguous S... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Adult... Stage I Adult B... Stage III Adult... Stage IV Adult ... Untreated Adult... Untreated Adult...	rasburicase allopurinol	18 Years -	Roswell Park Cancer Institute
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia	NCT00352365	Adult Acute Bas... Adult Acute Eos... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult...	lenalidomide	60 Years -	National Cancer Institute (NCI)
Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia	NCT02144675	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... Untreated Adult...	choline magnesi... idarubicin cytarabine laboratory biom...	18 Years -	Rutgers, The State University of New Jersey
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia	NCT01907815	Recurrent Adult... Untreated Adult...	Akt Inhibitor G... Laboratory Biom... Trametinib	18 Years -	National Cancer Institute (NCI)
Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia	NCT00528398	Leukemia	cytarabine idarubicin	16 Years - 60 Years	City of Hope Medical Center
Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia	NCT00703300	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Recurrent Adult... Secondary Acute... Untreated Adult...	bortezomib decitabine pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia	NCT01876953	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Recurrent Adult... Secondary Acute... Untreated Adult...	cytarabine idarubicin dasatinib laboratory biom...	18 Years -	City of Hope Medical Center
Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia	NCT02144675	Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... Untreated Adult...	choline magnesi... idarubicin cytarabine laboratory biom...	18 Years -	Rutgers, The State University of New Jersey
Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome	NCT00475150	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... de Novo Myelody... Previously Trea... Recurrent Adult... Secondary Acute... Secondary Myelo... Untreated Adult...	cediranib malea... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients	NCT02835222	Untreated Adult...	Cytarabine Daunorubicin Hy... Selinexor	18 Years -	Wake Forest University Health Sciences
Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer	NCT00064285	Leukemia	alvocidib imatinib mesyla...	18 Years -	Virginia Commonwealth University
Metabolic Changes in Blood Samples From Patients With Acute Myeloid Leukemia	NCT02581917	Recurrent Adult... Untreated Adult...	Cytology Specim... Laboratory Biom...	18 Years -	Wake Forest University Health Sciences
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia	NCT00003405	Leukemia	recombinant int... amifostine trih... bromodeoxyuridi... cytarabine idarubicin idoxuridine isotretinoin mitoxantrone hy...	0 Years - 70 Years	Rush University Medical Center
Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients	NCT02835222	Untreated Adult...	Cytarabine Daunorubicin Hy... Selinexor	18 Years -	Wake Forest University Health Sciences
Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome	NCT00002547	Leukemia Myelodysplastic...	busulfan cyclophosphamid... cyclosporine cytarabine methotrexate allogeneic bone... syngeneic bone ...	- 60 Years	Barbara Ann Karmanos Cancer Institute
PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia	NCT00093600	Acute Myeloid L...	cytarabine daunorubicin hy... midostaurin	18 Years - 60 Years	Novartis
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia	NCT00002658	Leukemia Neutropenia	filgrastim amsacrine cyclophosphamid... cytarabine daunorubicin hy... etoposide idarubicin mitoxantrone hy... thioguanine tretinoin allogeneic bone... autologous bone... peripheral bloo... radiation thera...	15 Years -	National Cancer Institute (NCI)
Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia	NCT00838240	Leukemia Myelodysplastic...	clofarabine cytarabine idarubicin	18 Years - 60 Years	European Organisation for Research and Treatment of Cancer - EORTC
Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 Mutations	NCT02323607	Recurrent Adult... Secondary Acute... Therapy-Related... Untreated Adult...	Pacritinib Cytarabine Daunorubicin Hy... Decitabine Laboratory Biom... Pharmacological...	18 Years -	Ohio State University Comprehensive Cancer Center
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes	NCT02044796	Acute Biphenoty... de Novo Myelody... Previously Trea... Recurrent Adult... Untreated Adult... Secondary Acute...	Cladribine Cytarabine Filgrastim Laboratory Biom... Mitoxantrone Hy...	18 Years -	Fred Hutchinson Cancer Center
Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia	NCT00275080	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Blastic Phase C... Extranodal Marg... Nodal Marginal ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Secondary Acute... Splenic Margina... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Grade... Stage III Grade... Stage III Grade... Stage III Mantl... Stage III Margi... Stage III Small... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Grade ... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Unspecified Adu... Untreated Adult... Untreated Adult...	vorinostat decitabine	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia	NCT00006363	Adult Acute Bas... Adult Acute Eos... Adult Acute Ery... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Acute... Childhood Myelo... de Novo Myelody... Untreated Adult... Untreated Child...	cytarabine daunorubicin hy... etoposide valspodar filgrastim busulfan autologous hema... peripheral bloo... aldesleukin clinical observ... pharmacological...	15 Years - 59 Years	National Cancer Institute (NCI)
Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome	NCT00516828	Leukemia Myelodysplastic...	cytarabine	60 Years -	Canadian Cancer Trials Group

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: